global parenteral nutrition market covers segments, by nutrient type (carbohydrates, amino acids, lipids, electrolytes and others (multivitamin formulations and trace elements)), dosage form (bags, vials, ampules, and bottles), end-user (clinics, hospitals, and others), size, trends, CAGR and forecast up to 2024
The report explores key players such as Fresenius Kabi, SichuanKelun Pharmaceutical Co., Ltd., Grifols International S.A, Claris LifeSciences Ltd., B. Braun Melsungen AG, Hospira
The main objective of this report is to define, describe, and forecast the global “Parenteral Nutrition” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).
It aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the market. The report attempts to forecast the market size for 5 major regions, namely, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America.
It contains key vendor profiles and comprehensively analyzes their core competencies. The report also tracks and analyzes competitive developments, including partnerships, collaborations, acquisitions, new product developments, and R&D activities in the market.
Get Sample Copy of this Report: www.infiniumglobalresearch.com/rep…mple-request/827
North America accounted for the largest market for parenteral nutrition over the past couple years with market share over 41%. The Europe accounted for the second largest market share after North America.
Presence of medical reimbursement facilities and technological advancements in the region are considered to be the key factors driving the dominance of North America in global parenteral nutrition market. The Asia-Pacific region is anticipated to grow at a CAGR of.
The growth of Asia pacific parenteral nutrition market is considered to be driven by rapidly increasing per capita healthcare expenditure and higher focus on research in parenteral nutrition by key players across the region. Developing economies in Asia pacific such as India and China are likely to bring more opportunities for major player over the forecast period.
Increasing cases of malnutrition are likely to provide opportunities for the key players in the world.
Malnutrition is one of the major issues in major countries in the world. Several underdeveloped and developing countries have a significant number of children suffering from malnutrition.
Children under the age of 5 are more vulnerable and face stunting and nutrition deficiency in the majority of these countries. The governments of several countries now have taken initiative to eradicate malnutrition among the children.
Since 1990 the global prevalence of stunting has decreased with an average annual rate of reduction of 2.1% per year during this period. The number of stunted children under-five years of age in the world has declined from an estimated 253 million (241, 265 million) in 1990 to 165 million (151, 179 million).
Access this Report: www.infiniumglobalresearch.com/rep…est-discount/827
Major Key Players mentioned in this Premium Report
The report provides profiles of the companies in the global parenteral nutrition market such as, Fresenius Kabi, SichuanKelun Pharmaceutical Co., Ltd., Grifols International S.A., Claris Lifesciences Ltd., B. Braun Melsungen AG, Hospira, Inc., and Baxter International, Inc.
Category: Market Research Publishers and RetailersCompany about: Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our c ...